- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, March 26, 2021
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by Health referenced a June 2019 contributor piece published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The contributor article, titled “The Deadly Costs of Insulin,” noted the significant price increases of insulin treatment, from $14 for 1 vial in 2001 to $275 in 2019.
A piece by Patheos spotlighted an article published on AJMC.com, titled “Mental Health Issues On the Rise Among Adolescents, Young Adults.” The article details rates of mood disorders and suicide-related outcomes that have increased significantly among adolescents and young adults, with a possible link to the rise of social media.
An article by Herald-Tribune cited a study published in the January 2021 issue of AJMC® titled “Differences in the Use of Telephone and Video Telemedicine Visits During the COVID-19 Pandemic.” The study found lower use of video vs telephone visits among older, Black, Hispanic, and Spanish-speaking patients amid the COVID-19 pandemic, driven largely by clinician and practice factors.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
